Renalytix plc (RNLXY) stock
RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)
Close on Oct 19, 2026Market cap $375.75MP/E –Yield –
Renalytix enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Renalytix's enterprise value was $588.96M on Oct 19, 2026, against $22.50B a year earlier. Over the last 5 years it ranged from $216.45M to $834.72B, with a median of $30.29B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $588.96M | -1.8% |
| 2025 | Dec 31, 2025 | $599.74M | -97.2% |
| 2024 | Dec 31, 2024 | $21.78B | -4.7% |
| 2023 | Dec 29, 2023 | $22.85B | -73.9% |
| 2022 | Dec 30, 2022 | $87.50B | -87.8% |
| 2021 | Dec 31, 2021 | $717.40B | +20.7% |
| 2020 | Dec 31, 2020 | $594.15B | – |
See a number that looks wrong?